{"id":233524,"date":"2024-09-30T00:00:00","date_gmt":"2024-09-30T00:00:00","guid":{"rendered":"http:\/\/clarivate.com\/life-sciences-healthcare\/report\/47041118-medtech-interventional-cardiology-devices-market\/"},"modified":"2026-04-17T23:03:19","modified_gmt":"2026-04-17T23:03:19","slug":"47042073-medtech-interventional-cardiology-devices-market-insights-asia-pacific","status":"publish","type":"report","link":"https:\/\/clarivate.com\/life-sciences-healthcare\/report\/47042073-medtech-interventional-cardiology-devices-market-insights-asia-pacific\/","title":{"rendered":"Interventional Cardiology Devices &#8211; Market Insights &#8211; Asia Pacific"},"content":{"rendered":"<p>The Asia Pacific <abbr title=\"Interventional Cardiology\">IC<\/abbr> device market is bolstered by a growing <abbr title=\"Coronary Artery Disease\">CAD<\/abbr> patient population, an increasing prevalence of complex lesions, enhanced access to treatment, a rising preference for minimally invasive procedures in <abbr title=\"Coronary Artery Disease\">CAD<\/abbr> cases, and the advent of technologically advanced, premium-priced diagnostic and treatment devices that offer case-specific diagnosis and intervention for <abbr title=\"Coronary Artery Disease\">CAD<\/abbr> cases of varying complexity. Going forward, the Asia Pacific <abbr title=\"Interventional Cardiology\">IC<\/abbr> device market is expected to expand <span>moderately<\/span>, driven by the growth in the coronary stent, balloon, and intravascular imaging and pressure guidewire segments.<\/p>\n<p>This Medtech 360 Report provides comprehensive data and analysis on the state of the interventional cardiology device market in Asia Pacific from 2019 through 2033.<\/p>\n<p><strong>A number of flagship devices have launched in the highly competitive <abbr title=\"Drug-Eluting Stent(s)\">DES<\/abbr> market.<\/strong><\/p>\n<p>How have the market dynamics changed with new launches?<\/p>\n<p>What competitive strategies competitors are deploying to gain share in this market?<\/p>\n<p>Which <abbr title=\"Drug-Eluting Stent(s)\">DES<\/abbr>\u00a0are in the pipeline to enter the market over the forecast period?<\/p>\n<p class=\"question-statement\"><strong>New technologies are changing the way complex <abbr title=\"Percutaneous Coronary Intervention\">PCI<\/abbr>s are diagnosed and treated.<\/strong><\/p>\n<p class=\"question-statement\">What is the impact of the latest generation of alternative coronary physiology modalities, such imaging-based <abbr title=\"Fractional Flow Reserve\">FFR<\/abbr><sub>angio<\/sub> and <abbr title=\"Fractional Flow Reserve\">FFR<\/abbr><sub><abbr title=\"Computed Tomography\">CT<\/abbr><\/sub>, on existing intravascular imaging technologies, including traditional <abbr title=\"Fractional Flow Reserve\">FFR<\/abbr> and <abbr title=\"Intravascular Ultrasound\">IVUS<\/abbr>?<\/p>\n<p>What is the expected impact of emerging balloon-based technologies, such as <abbr title=\"Drug-Coated Balloon\">DCB<\/abbr>s?<\/p>\n<p>How is the <abbr title=\"Bioresorbable Scaffold(s)\">BRS<\/abbr> segment performing in the Asia Pacific market?<\/p>\n<p>How are new clinical trials impacting <abbr title=\"Interventional Cardiology\">IC<\/abbr> device segments, procedures, competitors, and products?<\/p>\n<p>How is the uptake of noninvasive imaging technologies in the Asia Pacific <abbr title=\"Interventional Cardiology\">IC<\/abbr> device market?<\/p>\n<p><strong>Device <abbr title=\"Average Selling Price\">ASP<\/abbr> trends will play a significant role in determining market growth through 2033.<\/strong><\/p>\n<p>How will <abbr title=\"Average Selling Price\">ASP<\/abbr> trends vary by country? What factors will contribute to these differences?<\/p>\n<p>How will government-driven pricing pressures and increasing competition affect <abbr title=\"Average Selling Price\">ASP<\/abbr>s, and which product segments will be most impacted?<\/p>\n<p><strong>The introduction of intravascular lithotripsy has revolutionized the treatment of calcified coronary lesions and vessel preparation prior to stenting.<\/strong><\/p>\n<p>How has the commercialization of coronary lithotripsy impacted the use of other products used in the interventional cardiology space?<\/p>\n<p>How is reimbursement changing for coronary lithotripsy, and how will this affect the adoption of this technology?<\/p>\n","protected":false},"template":"","class_list":["post-233524","report","type-report","status-publish","hentry","report-gateway-medtech","medtech-therapy-area-cardiovascular","medtech-therapy-area-interventional-cardiology-devices","medtech-geography-asia-pacific","medtech-date-983"],"acf":[],"publishpress_future_workflow_manual_trigger":{"enabledWorkflows":[]},"_links":{"self":[{"href":"https:\/\/clarivate.com\/life-sciences-healthcare\/wp-json\/wp\/v2\/report\/233524","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/clarivate.com\/life-sciences-healthcare\/wp-json\/wp\/v2\/report"}],"about":[{"href":"https:\/\/clarivate.com\/life-sciences-healthcare\/wp-json\/wp\/v2\/types\/report"}],"version-history":[{"count":2,"href":"https:\/\/clarivate.com\/life-sciences-healthcare\/wp-json\/wp\/v2\/report\/233524\/revisions"}],"predecessor-version":[{"id":305720,"href":"https:\/\/clarivate.com\/life-sciences-healthcare\/wp-json\/wp\/v2\/report\/233524\/revisions\/305720"}],"wp:attachment":[{"href":"https:\/\/clarivate.com\/life-sciences-healthcare\/wp-json\/wp\/v2\/media?parent=233524"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}